chr4-163351287-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006174.4(NPY5R):c.1014G>T(p.Glu338Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000107 in 1,613,934 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006174.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NPY5R | NM_006174.4 | c.1014G>T | p.Glu338Asp | missense_variant | 4/4 | ENST00000338566.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NPY5R | ENST00000338566.8 | c.1014G>T | p.Glu338Asp | missense_variant | 4/4 | 1 | NM_006174.4 | P1 | |
NPY5R | ENST00000506953.1 | c.1014G>T | p.Glu338Asp | missense_variant | 1/1 | P1 | |||
NPY5R | ENST00000515560.1 | c.1014G>T | p.Glu338Asp | missense_variant | 4/4 | 2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000637 AC: 97AN: 152190Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000111 AC: 28AN: 251206Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135784
GnomAD4 exome AF: 0.0000520 AC: 76AN: 1461626Hom.: 0 Cov.: 33 AF XY: 0.0000440 AC XY: 32AN XY: 727120
GnomAD4 genome AF: 0.000637 AC: 97AN: 152308Hom.: 0 Cov.: 32 AF XY: 0.000712 AC XY: 53AN XY: 74488
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 15, 2023 | The c.1014G>T (p.E338D) alteration is located in exon 4 (coding exon 1) of the NPY5R gene. This alteration results from a G to T substitution at nucleotide position 1014, causing the glutamic acid (E) at amino acid position 338 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at